Literature DB >> 20191126

Histological changes in the kidneys of experimental diabetic rats fed with Momordica charantia (bitter gourd) extract.

S L Teoh1, Azian Abd Latiff, S Das.   

Abstract

Momordica charantia (MC) or bitter gourd is widely known for its antidiabetic properties. The aim of the present study was to observe the protective effect of MC extract on the kidneys of streptozotocin-induced diabetic rats. Eighteen male Sprague-Dawley rats (n=18) weighing 200+/-50 g were taken for the study. The study comprised of three groups i.e. a non-diabetic, diabetic untreated and diabetic treated with MC extract, with each group comprising of six (n=6) rats. Diabetes was induced in the overnight fasted rats by intramuscular injection of streptozotocin (50 mg/kg body weight). The MC extract (50 mg/kg body weight) was administered via oral gavage. Both the kidneys were collected on the tenth day following treatment. Histological study using Verhoeff's van Gieson (VvG) and Periodic Acid-Schiff (PAS) stains were performed. The kidneys of the diabetic rats showed thickening of the basement membrane of the Bowman's capsule, edema and hypercellurarity of the proximal tubules, necrosis and hyaline deposits. These features were found to be reversed when the MC extract was administered to the experimental animals. The MC extract acted as an antioxidant thereby preventing the oxidative damage involved in the diabetic kidney. The administration of MC extract prevents oxidative damage in diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20191126

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  12 in total

1.  Calorie restriction-induced SIRT6 activation delays aging by suppressing NF-κB signaling.

Authors:  Nannan Zhang; Zhongchi Li; Wei Mu; Liyuan Li; Yaru Liang; Maoyang Lu; Zhuoran Wang; Ying Qiu; Zhao Wang
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

Review 2.  Bitter melon: a panacea for inflammation and cancer.

Authors:  Prasad R Dandawate; Dharmalingam Subramaniam; Subhash B Padhye; Shrikant Anant
Journal:  Chin J Nat Med       Date:  2016-02

3.  Hypoglycaemic and tissue-protective effects of the aqueous extract of persea americana seeds on alloxan-induced albino rats.

Authors:  Anthonet Ndidi Ezejiofor; Abednego Okorie; Orish Ebere Orisakwe
Journal:  Malays J Med Sci       Date:  2013-10

4.  Impact of Momordica charantia extract on kidney function and structure in mice.

Authors:  Saeed Mardani; Hamid Nasri; Shabnam Hajian; Ali Ahmadi; Reyhane Kazemi; Mahmoud Rafieian-Kopaei
Journal:  J Nephropathol       Date:  2014-01-01

5.  Antidiabetic effect of Sida cordata in alloxan induced diabetic rats.

Authors:  Naseer Ali Shah; Muhammad Rashid Khan
Journal:  Biomed Res Int       Date:  2014-07-09       Impact factor: 3.411

6.  Dietary zinc modifies diabetic-induced renal pathology in rats.

Authors:  Wael M Elsaed; Hazem Abdelhamid Mohamed
Journal:  Ren Fail       Date:  2016-11-24       Impact factor: 2.606

7.  Antihyperlipidemic screening and plasma uric acid reducing potential of Momordica charantia seeds on Swiss albino mice model.

Authors:  Md Saddam Hussain; Nusrat Jahan; Md Mamun Or Rashid; Mohammad Salim Hossain; Umay Chen; Naimur Rahman
Journal:  Heliyon       Date:  2019-05-17

8.  Acute interstitial nephritis associated with ingesting a Momordica charantia extract: A case report.

Authors:  Wooram Bae; Seongmin Kim; Jungyoon Choi; Tae Won Lee; Eunjin Bae; Ha Nee Jang; Sehyun Jung; Seunghye Lee; Se-Ho Chang; Dong Jun Park
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

9.  Effect of Croatian propolis on diabetic nephropathy and liver toxicity in mice.

Authors:  Nada Oršolić; Damir Sirovina; Marijana Zovko Končić; Gordana Lacković; Gordana Gregorović
Journal:  BMC Complement Altern Med       Date:  2012-08-06       Impact factor: 3.659

Review 10.  Overview of Botanical Status in EU, USA, and Thailand.

Authors:  Weena Jiratchariyakul; Gail B Mahady
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-21       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.